Facebook tracking pixel
F11.20
ICD-10-CM
Opioid Use Disorder

Find comprehensive information on Opioid Use Disorder diagnosis, including clinical documentation requirements, ICD-10-CM codes (F11.10, F11.20), DSM-5 criteria, medical coding guidelines, and best practices for healthcare professionals. Learn about opioid dependence treatment, substance use disorder documentation, and accurate coding for reimbursement. This resource provides essential information for clinicians, coders, and healthcare providers involved in the diagnosis and management of Opioid Use Disorder.

Also known as

OUD
Opioid Addiction
Opioid Dependence
+1 more

Diagnosis Snapshot

Key Facts
  • Definition : Problematic opioid use leading to clinically significant impairment or distress.
  • Clinical Signs : Cravings, tolerance, withdrawal, neglecting responsibilities, continued use despite negative consequences.
  • Common Settings : Primary care, addiction treatment centers, emergency rooms, telehealth platforms.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC F11.20 Coding
F11.10-F11.99

Opioid Use Disorder

Covers various opioid use disorders, including dependence and abuse.

F11.00-F11.09

Opioid Abuse

Harmful opioid use without dependence.

T40.0X1A-T40.6X4A

Poisoning by Opioids

Adverse effects from opioid overdose or exposure.

Z79.891

Long-term (current) use of opioids

Indicates current long-term opioid use, not necessarily disorder.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is opioid use problematic?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Problematic opioid use leading to impairment.
Opioid withdrawal symptoms after cessation.
Opioid induced mental disorders.

Documentation Best Practices

Documentation Checklist
  • Opioid Use Disorder ICD-10 F11.10 diagnosis documentation
  • Document DSM-5 criteria: impaired control, craving, risky use
  • Social/occupational impairment: note specific examples
  • Withdrawal symptoms: record onset, duration, severity
  • Tolerance: document increasing dose needed for same effect

Coding and Audit Risks

Common Risks
  • Unspecified Opioid

    Coding opioid use disorder without specifying the opioid type (e.g., heroin, fentanyl) leads to inaccurate data and potential undercoding.

  • Remission Status

    Failing to document and code the remission status (early, sustained, in maintenance) impacts quality reporting and reimbursement.

  • Comorbid Conditions

    Overlooking co-occurring mental health disorders (e.g., depression, anxiety) with opioid use disorder results in incomplete clinical picture and missed HCCs.

Mitigation Tips

Best Practices
  • ICD-10 F11.10, validate opioid dependence, CDI compliant documentation.
  • DSM-5 criteria, toxicology, assess opioid abuse, optimize coding accuracy.
  • Urine drug screen, prescription monitoring, improve healthcare compliance.
  • Document opioid cravings, withdrawal symptoms, ensure complete medical coding.
  • Interdisciplinary approach, treatment plan, enhance CDI, ensure compliance.

Clinical Decision Support

Checklist
  • 1. DSM-5 criteria met? ICD-10 F11.10, F11.1x documented
  • 2. Toxicology screen positive? Document opioid type
  • 3. Assess opioid use frequency, amount, duration
  • 4. Evaluate for withdrawal symptoms, cravings
  • 5. Consider patient safety risks, overdose risk factors

Reimbursement and Quality Metrics

Impact Summary
  • Opioid Use Disorder reimbursement hinges on accurate ICD-10-CM F11. coding, impacting claim denial rates and hospital revenue cycle.
  • Quality metrics for OUD treatment tie to medication adherence, therapy engagement, and remission rates, affecting hospital performance scores.
  • Accurate OUD coding (F11.-) supports data-driven interventions, improves patient outcomes, and reduces readmissions.
  • OUD diagnosis coding precision enables appropriate resource allocation and justifies funding for addiction treatment programs.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Document opioid dependence criteria
  • Code F11.10 for OUD diagnosis
  • Specify opioid type if known
  • Check for co-occurring SUD, F11.20
  • Review DSM-5 criteria for OUD

Documentation Templates

Patient presents with features suggestive of Opioid Use Disorder (OUD).  Presenting concerns include opioid cravings, opioid withdrawal symptoms, and escalating opioid use despite adverse consequences.  Patient reports a history of prescription opioid use for chronic back pain that has progressed to daily use exceeding prescribed dosage.  Symptoms consistent with opioid dependence include tolerance, withdrawal, and unsuccessful attempts to cut down or quit.  Patient acknowledges a preoccupation with obtaining and using opioids, neglecting social and occupational responsibilities.  Physical examination reveals mild pupillary constriction and evidence of intravenous drug use with track marks on the arms.  Patient denies current suicidal or homicidal ideation.  Assessment includes review of past medical history, mental health history, substance use history, and family history of addiction.  Urine drug screen is positive for opioids.  Diagnosis of Opioid Use Disorder (OUD) is made based on DSM-5 criteria.  Differential diagnosis includes chronic pain syndrome, anxiety disorders, and other substance use disorders.  Treatment plan includes referral to addiction specialist for medication-assisted treatment (MAT) with buprenorphine naloxone.  Patient education provided on opioid overdose prevention, naloxone administration, and community resources for addiction support.  Patient agrees to follow-up appointments for monitoring of treatment progress and ongoing support.  ICD-10 code F11.20 is assigned for Opioid Use Disorder, uncomplicated.  CPT codes for evaluation and management services will be billed accordingly.  Prognosis is guarded but hopeful with adherence to treatment recommendations.  Continued monitoring and support are crucial for long-term recovery.